HopeStage
Back to all studies
RecruitingNCT07227948

Semaglutide with CBT for cocaine use

About this title

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder

Read the official source — NCT07227948
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 15, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
75
Sponsor
The University of Texas Health Science Center, Houston
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07227948
Official title
Show the full official title

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study

Recruitment & locations

Currently recruiting

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Texas Health Science Center, Houston, a university.

Does this study involve medication?

Yes. The study involves medication, including Semaglutide and Placebo.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies